Efficacy of golimumab in early axial spondyloarthritis (axSpA) in relation to gut inflammation, an early remission induction study (GO GUT).
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Golimumab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms GO GUT
- 11 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Sep 2017.
- 22 Aug 2017 New trial record